scholarly journals Researchers Target Transcription Factor for Treating Pancreatic Cancer

2021 ◽  
Vol 43 (10) ◽  
pp. 35-35
Author(s):  
Kurt Samson
2016 ◽  
Vol 151 (3) ◽  
pp. 540-553.e14 ◽  
Author(s):  
Steffen Heeg ◽  
Koushik K. Das ◽  
Maximilian Reichert ◽  
Basil Bakir ◽  
Shigetsugu Takano ◽  
...  

2012 ◽  
Author(s):  
Sulagna Banerjee ◽  
Veena Sangwan ◽  
Olivia McGinn ◽  
Tara Kendall Krosch ◽  
Nameeta Mujumder ◽  
...  

Mutagenesis ◽  
2019 ◽  
Vol 34 (5-6) ◽  
pp. 375-389 ◽  
Author(s):  
Kerstin Huebner ◽  
Jan Procházka ◽  
Ana C Monteiro ◽  
Vijayalakshmi Mahadevan ◽  
Regine Schneider-Stock

Abstract In contrast to the continuous increase in survival rates for many cancer entities, colorectal cancer (CRC) and pancreatic cancer are predicted to be ranked among the top 3 cancer-related deaths in the European Union by 2025. Especially, fighting metastasis still constitutes an obstacle to be overcome in CRC and pancreatic cancer. As described by Fearon and Vogelstein, the development of CRC is based on sequential mutations leading to the activation of proto-oncogenes and the inactivation of tumour suppressor genes. In pancreatic cancer, genetic alterations also attribute to tumour development and progression. Recent findings have identified new potentially important transcription factors in CRC, among those the activating transcription factor 2 (ATF2). ATF2 is a basic leucine zipper protein and is involved in physiological and developmental processes, as well as in tumorigenesis. The mutation burden of ATF2 in CRC and pancreatic cancer is rather negligible; however, previous studies in other tumours indicated that ATF2 expression level and subcellular localisation impact tumour progression and patient prognosis. In a tissue- and stimulus-dependent manner, ATF2 is activated by upstream kinases, dimerises and induces target gene expression. Dependent on its dimerisation partner, ATF2 homodimers or heterodimers bind to cAMP-response elements or activator protein 1 consensus motifs. Pioneering work has been performed in melanoma in which the dual role of ATF2 is best understood. Even though there is increasing interest in ATF2 recently, only little is known about its involvement in CRC and pancreatic cancer. In this review, we summarise the current understanding of the underestimated ‘cancer gene chameleon’ ATF2 in apoptosis, epithelial-to-mesenchymal transition and microRNA regulation and highlight its functions in CRC and pancreatic cancer. We further provide a novel ATF2 3D structure with key phosphorylation sites and an updated overview of all so-far available mouse models to study ATF2 in vivo.


2017 ◽  
Vol 114 (14) ◽  
pp. 3684-3689 ◽  
Author(s):  
Guang Li ◽  
Xian Liu ◽  
Chaofan Xing ◽  
Huayang Zhang ◽  
Sebastian M. Shimeld ◽  
...  

Many bilaterally symmetrical animals develop genetically programmed left–right asymmetries. In vertebrates, this process is under the control of Nodal signaling, which is restricted to the left side by Nodal antagonists Cerberus and Lefty. Amphioxus, the earliest diverging chordate lineage, has profound left–right asymmetry as a larva. We show that Cerberus, Nodal, Lefty, and their target transcription factor Pitx are sequentially activated in amphioxus embryos. We then address their function by transcription activator-like effector nucleases (TALEN)-based knockout and heat-shock promoter (HSP)-driven overexpression. Knockout of Cerberus leads to ectopic right-sided expression of Nodal, Lefty, and Pitx, whereas overexpression of Cerberus represses their left-sided expression. Overexpression of Nodal in turn represses Cerberus and activates Lefty and Pitx ectopically on the right side. We also show Lefty represses Nodal, whereas Pitx activates Nodal. These data combine in a model in which Cerberus determines whether the left-sided gene expression cassette is activated or repressed. These regulatory steps are essential for normal left–right asymmetry to develop, as when they are disrupted embryos may instead form two phenotypic left sides or two phenotypic right sides. Our study shows the regulatory cassette controlling left–right asymmetry was in place in the ancestor of amphioxus and vertebrates. This includes the Nodal inhibitors Cerberus and Lefty, both of which operate in feedback loops with Nodal and combine to establish asymmetric Pitx expression. Cerberus and Lefty are missing from most invertebrate lineages, marking this mechanism as an innovation in the lineage leading to modern chordates.


2014 ◽  
Vol 8 (5) ◽  
pp. 1054-1054
Author(s):  
Shigeru Horiguchi ◽  
Hidenori Shiraha ◽  
Teruya Nagahara ◽  
Jyunnro Kataoka ◽  
Masaya Iwamuro ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document